Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Short Interest Down 8.1% in December

[ad_1]

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 8,720,000 shares, a drop of 8.1% from the November 30th total of 9,490,000 shares. Approximately 8.2% of the company’s shares are short sold. Based on an average daily volume of 1,340,000 shares, the short-interest ratio is currently 6.5 days.

Insider Buying and Selling

In other Allscripts Healthcare Solutions news, SVP Tejal Vakharia sold 8,642 shares of the firm’s stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $18.42, for a total value of $159,185.64. Following the completion of the transaction, the senior vice president now owns 222,604 shares of the company’s stock, valued at approximately $4,100,365.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Allscripts Healthcare Solutions news, Director David B. Stevens sold 43,134 shares of the firm’s stock in a transaction that occurred on Tuesday, December 6th. The shares were sold at an average price of $18.47, for a total value of $796,684.98. Following the completion of the transaction, the director now owns 32,384 shares of the company’s stock, valued at approximately $598,132.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Tejal Vakharia sold 8,642 shares of the firm’s stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $18.42, for a total transaction of $159,185.64. Following the completion of the transaction, the senior vice president now directly owns 222,604 shares of the company’s stock, valued at approximately $4,100,365.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 61,776 shares of company stock valued at $1,137,271. Company insiders own 2.29% of the company’s stock.

Institutional Trading of Allscripts Healthcare Solutions

Hedge funds and other institutional investors have recently made changes to their positions in the company. Nordea Investment Management AB boosted its holdings in shares of Allscripts Healthcare Solutions by 41.0% in the second quarter. Nordea Investment Management AB now owns 180,145 shares of the software maker’s stock valued at $2,682,000 after acquiring an additional 52,387 shares in the last quarter. Brandywine Oak Private Wealth LLC boosted its holdings in Allscripts Healthcare Solutions by 21.5% during the second quarter. Brandywine Oak Private Wealth LLC now owns 18,253 shares of the software maker’s stock worth $270,000 after buying an additional 3,226 shares in the last quarter. Trexquant Investment LP boosted its holdings in Allscripts Healthcare Solutions by 239.0% during the second quarter. Trexquant Investment LP now owns 83,797 shares of the software maker’s stock worth $1,243,000 after buying an additional 59,081 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Allscripts Healthcare Solutions during the second quarter worth about $12,807,000. Finally, Millennium Management LLC boosted its holdings in Allscripts Healthcare Solutions by 72.7% during the second quarter. Millennium Management LLC now owns 2,480,364 shares of the software maker’s stock worth $36,784,000 after buying an additional 1,044,236 shares in the last quarter. Hedge funds and other institutional investors own 99.76% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on MDRX shares. The Goldman Sachs Group upgraded shares of Allscripts Healthcare Solutions from a “neutral” rating to a “buy” rating and raised their price objective for the company from $22.00 to $23.00 in a report on Tuesday, November 8th. StockNews.com started coverage on shares of Allscripts Healthcare Solutions in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Argus upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $26.00 price objective on the stock in a report on Wednesday, December 7th. They noted that the move was a valuation call. TheStreet upgraded shares of Allscripts Healthcare Solutions from a “c+” rating to a “b-” rating in a report on Wednesday, November 30th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Allscripts Healthcare Solutions from $19.00 to $20.00 and gave the stock an “underweight” rating in a research note on Friday, November 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $22.67.

Allscripts Healthcare Solutions Trading Down 1.3 %

NASDAQ MDRX opened at $17.64 on Tuesday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market cap of $1.93 billion, a PE ratio of 41.02, a P/E/G ratio of 1.62 and a beta of 1.01. Allscripts Healthcare Solutions has a one year low of $13.59 and a one year high of $23.25. The firm’s fifty day moving average is $17.52 and its two-hundred day moving average is $16.40.

Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last posted its quarterly earnings data on Thursday, November 3rd. The software maker reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.05. The company had revenue of $151.90 million for the quarter, compared to analyst estimates of $152.79 million. Allscripts Healthcare Solutions had a net margin of 7.25% and a return on equity of 10.74%. Allscripts Healthcare Solutions’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.21 earnings per share. Analysts expect that Allscripts Healthcare Solutions will post 0.68 earnings per share for the current year.

Allscripts Healthcare Solutions Company Profile

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.